Financial Statement

Ebix, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands, except share amounts)
  June 30,
2020		 December 31,
2019
 
ASSETS (Unaudited)  
Current assets:    
Cash and cash equivalents $77,315 $73,228
Receivables from service providers 13,226 25,607
Short-term investments 31,357 4,443
Restricted cash 7,883 35,051
Fiduciary funds - restricted 4,500 4,966
Trade accounts receivable, less allowances of $20,634 and $21,696, respectively 129,768 153,565
Other current assets 63,880 67,074
Total current assets 327,929 363,934
 
Property and equipment, net 48,310 48,421
Right-of-use assets 14,747 19,544
Goodwill 925,355 952,404
Intangibles, net 40,560 46,955
Indefinite-lived intangibles 42,055 42,055
Capitalized software development costs, net 19,732 19,183
Deferred tax asset, net 66,605 69,227
Other assets 30,683 29,896
Total assets $1,515,976 $1,591,619
     
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Current liabilities:    
Accounts payable and accrued liabilities $69,903 $84,735
Payables to service agents 4,394 12,196
Accrued payroll and related benefits 10,789 8,755
Working capital facility 7,615 28,352
Fiduciary funds - restricted 4,500 4,966
Short-term debt 984 1,167
Contingent liability for accrued earn-out acquisition consideration 6,122 8,621
Current portion of long term debt and financing lease obligations, net of deferred financing costs of $920 and $575, respectively 23,620 22,091
Contract liabilities 29,013 28,712
Lease liability 4,739 5,955
Other current liabilities 36,308 29,335
Total current liabilities 197,987 234,885
 
Revolving line of credit 439,402 438,037
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $1,524 and $1,534, respectively 243,074 254,467
Contingent liability for accrued earn-out acquisition consideration - 1,474
Contract liabilities 7,334 8,541
Lease liability 9,829 13,196
Deferred tax liability, net 1,235 1,235
Other liabilities 27,589 40,339
Total liabilities 926,450 992,174
 
Commitments and Contingencies    
 
Stockholders’ equity:    
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at June 30, 2020 and December 31, 2019 — —
Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at June 30, 2020 and no shares authorized, issue and outstanding at December 31, 2019 — —
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,507,903 issued and outstanding, at June 30, 2020, and 30,492,044 issued and outstanding at December 31, 2019 3,051 3,049
Additional paid-in capital 9,335 6,960
Retained earnings 660,767 618,503
Accumulated other comprehensive loss (132,469) (78,398)
Total Ebix, Inc. stockholders’ equity 540,684 550,114
Noncontrolling interest 48,842 49,331
Total stockholders’ equity 589,526 599,445
Total liabilities and stockholders’ equity $ 1,515,976 $ 1,591,619
Investor Home

Investor Contacts

EBIX Inc
1 Ebix Way, Johns Creek, Georgia 30097
Ph: 678-281-2027 Fax: 678-281-2019

IR@ebix.com

David Collins, Tanya Kamatu, Chris Eddy
Catalyst Global - 212-924-9800 or ebix@catalyst-ir.com

Ebix Named in Fortune’s 2017 100 Fastest-Growing Companies

Follow us

   

Ebix Inc.
1 Ebix Way, Johns Creek,
GA 30097

Tel: +1 (678) 281-2020
Fax: +1 (678) 281-2019

  • Join Us

Copyright © 2022 Ebix Inc. Terms Of Use | Privacy Statement